After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...